Yoyen-Ermis, D. Et Al. 2018. Tumor-Induced Myeloid Cells Are Reduced by Gemcitabine-Loaded PAMAM Dendrimers Decorated with Anti-Flt1 Antibody. MOLECULAR PHARMACEUTICS , vol.15, no.4 , 1526-1533.

Yoyen-Ermis, D., Ozturk-Atar, K., KURŞUNEL, M. A., Aydin, C., Ozkazanc, D., Gurbuz, M. U., ... ÜNER, A.(2018). Tumor-Induced Myeloid Cells Are Reduced by Gemcitabine-Loaded PAMAM Dendrimers Decorated with Anti-Flt1 Antibody. MOLECULAR PHARMACEUTICS , vol.15, no.4, 1526-1533.

Yoyen-Ermis, Digdem Et Al. "Tumor-Induced Myeloid Cells Are Reduced by Gemcitabine-Loaded PAMAM Dendrimers Decorated with Anti-Flt1 Antibody," MOLECULAR PHARMACEUTICS , vol.15, no.4, 1526-1533, 2018

Yoyen-Ermis, Digdem Et Al. "Tumor-Induced Myeloid Cells Are Reduced by Gemcitabine-Loaded PAMAM Dendrimers Decorated with Anti-Flt1 Antibody." MOLECULAR PHARMACEUTICS , vol.15, no.4, pp.1526-1533, 2018

Yoyen-Ermis, D. Et Al. (2018) . "Tumor-Induced Myeloid Cells Are Reduced by Gemcitabine-Loaded PAMAM Dendrimers Decorated with Anti-Flt1 Antibody." MOLECULAR PHARMACEUTICS , vol.15, no.4, pp.1526-1533.

@article{article, author={Digdem Yoyen-Ermis Et Al. }, title={Tumor-Induced Myeloid Cells Are Reduced by Gemcitabine-Loaded PAMAM Dendrimers Decorated with Anti-Flt1 Antibody}, journal={MOLECULAR PHARMACEUTICS}, year=2018, pages={1526-1533} }